Table 3.
Pharmacokinetic parameters obtained alter the oral administration of 100:25 mg/kg levodopa/carbidopa in the three groups studied (initial situation; treatment with Plantago ovata husk and treatment with placebo) to 18 Parkinson patients
| Initial situation | Treatment A (Plantago ovata husk) | Treatment B (Placebo) | |
|---|---|---|---|
| Glucose (mg/100 ml) | 105.50 ± 10.65 | 96.56 ± 10.62 | 98.06 ± 13.40 |
| Urea (mg/100 ml) | 42.96 ± 9.50 | 43.43 ± 11.76 | 45.93 ± 12.50 |
| Creatinine (mg/100 ml) | 0.89 ± 0.17 | 0.85 ± 0.15 | 0.86 ± 0.15 |
| Tryglicerides (mg/100 ml) | 94.83 ± 42.39 | 84.33 ± 29.28 | 94.11 ± 43.73 |
| Total cholesterol (mg/100 ml) | 214.39 ± 36.92 | 191.89 ± 27.73 | 209.50 ± 36.65 |
| AST (GOT) (UI/l) | 21.22 ± 4.49 | 19.94 ± 4.47 | 20.33 ± 4.34 |
| ALT (GPT) (UI/l) | 25.67 ± 8.98 | 25.06 ± 9.51 | 26.00 ± 9.29 |
| Alkaline phosphatase (UI/l) | 131.44 ± 43.91 | 124.00 ± 40.68 | 126.00 ± 44.13 |
| GGT (UI/l) | 17.06 ± 6.55 | 16.00 ± 6.15 | 19.85 ± 10.63 |
| LDL (mg/100 ml) | 135.18 ± 29.30 | 117.67 ± 22.23 | 132.32 ± 33.00 |
| HDL (mg/100 ml) | 60.17 ± 13.90 | 57.33 ± 15.91 | 58.33 ± 12.34 |